Weill Medical College Of Cornell University
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1865-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://weill.cornell.edu
Randomized Trial Comparing Partial Resection of Inferior Turbinate(PRIT) and Radiofrequency Ablation(RFA) for Inferior Turbinate Reduction
Not Applicable
Withdrawn
- Conditions
- Turbinate HypertrophyNasal ObstructionSeptal Deformity
- Interventions
- Procedure: Radiofrequency Ablation (RFA)Procedure: Partial Resection of Inferior Turbinates (PRIT)
- First Posted Date
- 2006-07-31
- Last Posted Date
- 2016-02-26
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00358267
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
The Effects of Potassium Citrate on Bone Metabolism
Phase 4
Completed
- Conditions
- Osteoporosis, PostmenopausalBone Diseases, Metabolic
- Interventions
- First Posted Date
- 2006-07-27
- Last Posted Date
- 2017-06-12
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 83
- Registration Number
- NCT00357331
- Locations
- 🇺🇸
Weill Cornell Medical College, New York, New York, United States
Comparison of Psychotherapy Programs to Treat Panic Disorder
Phase 3
Completed
- Conditions
- Anxiety DisordersPanic DisorderAgoraphobia
- Interventions
- Behavioral: Applied relaxation training (ART)Behavioral: Panic focused psychodynamic psychotherapy (PFPP)Behavioral: Cognitive behavioral therapy
- First Posted Date
- 2006-07-18
- Last Posted Date
- 2022-12-23
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 201
- Registration Number
- NCT00353470
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
🇺🇸University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, United States
Safety Study on the Transfer of the CD40 Ligand Gene (AdcuCD40L) to Patients With Esophageal Carcinoma
Phase 1
Withdrawn
- Conditions
- Esophageal Neoplasms
- Interventions
- Genetic: CD40 Gene Transfer
- First Posted Date
- 2006-05-24
- Last Posted Date
- 2016-05-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00328887
- Locations
- 🇺🇸
The Valley Hospital, Ridgewood, New Jersey, United States
🇺🇸Weill Medical College of Cornell University, New York, New York, United States
Urine Chloride/Creatinine Ratio for Estimation of Urine Sodium
Completed
- Conditions
- Hypertension
- First Posted Date
- 2006-05-11
- Last Posted Date
- 2013-07-09
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 81
- Registration Number
- NCT00324883
- Locations
- 🇺🇸
Weill Cornell Medical College of Cornell University, New York, New York, United States
Anti-Pseudomonas Immune Status and Dendritic Cell Preparation in Normal Individuals
Completed
- Conditions
- Healthy
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 8
- Registration Number
- NCT00320164
Collection of Blood for Gene Expression Study in Individuals With Chronic Lung Diseases
Completed
- Conditions
- Pulmonary Diseases
- First Posted Date
- 2006-05-03
- Last Posted Date
- 2017-05-24
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 3087
- Registration Number
- NCT00320151
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York, New York, United States
Role of Vascular Endothelial Growth Factor (VEGF) in Acute Lung Injury/Adult Respiratory Distress Syndrome (ARDS)
Withdrawn
- Conditions
- Respiratory Distress Syndrome, Adult
- First Posted Date
- 2006-04-27
- Last Posted Date
- 2017-01-30
- Lead Sponsor
- Weill Medical College of Cornell University
- Registration Number
- NCT00319631
- Locations
- 🇺🇸
Weill Medical College of Cornell University, New York City, New York, United States
Islet Cell Transplants for Diabetes
Phase 1
Terminated
- Conditions
- Diabetes Mellitus, Type 1
- Interventions
- Drug: Islet Cell Transplantation
- First Posted Date
- 2006-03-15
- Last Posted Date
- 2019-06-03
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 3
- Registration Number
- NCT00303134
- Locations
- 🇺🇸
New York Presbyterian Hospital - Weill Cornell Medical Center, New York, New York, United States
Comparison of PEG-Intron and Two Different Doses of Ribavirin for the Treatment of Chronic Hepatitis C In Treatment Naïve Subjects
Phase 3
Completed
- Conditions
- Chronic Hepatitis C
- First Posted Date
- 2006-03-07
- Last Posted Date
- 2006-03-07
- Lead Sponsor
- Weill Medical College of Cornell University
- Target Recruit Count
- 5000
- Registration Number
- NCT00299936
© Copyright 2025. All Rights Reserved by MedPath